
Opinion|Videos|April 30, 2024
Risk and Value-Based Contracting for Prescription Drug Therapeutics and Manufacturer’s Support in Utilization
Mahsa Salsabili, PharmD, PhD, explores risk and value-based contracting for prescription digital therapeutics, along with strategies for manufacturers to support their utilization and optimization, while also delving into cost-effectiveness modeling and budget impact analysis.
Advertisement
Episodes in this series

Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement






















